Tang C, et al. - Researchers in this retrospective analysis sought to determine the predictors of acute hematologic toxicities during definitive chemoradiation for non–small cell lung cancer (NSCLC). They identified a marked correlation of chemotherapy, specifically the nonplatinum agent, with grade ≥3 hematologic toxicities, whereas radiation modality showed no correlation.